awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35096240-2C66017D-B443-41E1-8809-0C4B2AAF7E0A
Q35096240-2C66017D-B443-41E1-8809-0C4B2AAF7E0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35096240-2C66017D-B443-41E1-8809-0C4B2AAF7E0A
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia
P2860
Q35096240-2C66017D-B443-41E1-8809-0C4B2AAF7E0A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35096240-2C66017D-B443-41E1-8809-0C4B2AAF7E0A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3f7b3811128343ec2d6515e35d9e1a41e1ccdb74
P2860
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.